Pathology | LabMedica International The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties. https://www.labmedica.com Mon, 20 Jul 2026 09:12:39 +0100 FeedCreator 1.7.2 Imaging Platform Maps Lipid Accumulations in Fabry Heart Tissue https://www.labmedica.com/pathology/articles/294811926/imaging-platform-maps-lipid-accumulations-in-fabry-heart-tissue.html A combined imaging method maps a Fabry-related molecule in heart tissue at very high resolution. Imaging Platform Maps Lipid Accumulations in Fabry Heart Tissue - Imaging Platform Maps Lipid Accumulations in Fabry Heart Tissue Thu, 16 Jul 2026 00:46:04 +0100 AI Tissue Imaging Helps Guide Targeted Therapy for Lung Cancer https://www.labmedica.com/pathology/articles/294811939/ai-tissue-imaging-helps-guide-targeted-therapy-for-lung-cancer.html An AI imaging approach predicts key lung cancer mutations from routine biopsy samples. AI Tissue Imaging Helps Guide Targeted Therapy for Lung Cancer - AI Tissue Imaging Helps Guide Targeted Therapy for Lung Cancer Tue, 14 Jul 2026 21:53:38 +0100 Tissue-Based Gene Signature Signals Colorectal Cancer Recurrence Risk https://www.labmedica.com/pathology/articles/294811875/tissue-based-gene-signature-signals-colorectal-cancer-recurrence-risk.html A new tissue-based six-gene signature in CRC liver micrometastases signals MRD, recurrence risk, and chemotherapy resistance. Tissue-Based Gene Signature Signals Colorectal Cancer Recurrence Risk - Tissue-Based Gene Signature Signals Colorectal Cancer Recurrence Risk Tue, 14 Jul 2026 21:50:55 +0100 FDA-Approved Companion Diagnostic Detects PTEN Loss in Prostate Cancer https://www.labmedica.com/pathology/articles/294811872/fda-approved-companion-diagnostic-detects-pten-loss-in-prostate-cancer.html NeoGenomics has launched the first IHC companion diagnostic test approved by the U.S. FDA for patients with prostate adenocarcinoma.  FDA-Approved Companion Diagnostic Detects PTEN Loss in Prostate Cancer - FDA-Approved Companion Diagnostic Detects PTEN Loss in Prostate Cancer Mon, 13 Jul 2026 11:46:32 +0100 New AI Test Delivers Rapid Breast Cancer Recurrence Predictions https://www.labmedica.com/pathology/articles/294811812/new-ai-test-delivers-rapid-breast-cancer-recurrence-predictions.html An AI test estimates breast cancer recurrence risk from routine slides and data, matching genomic assays and enabling faster care. New AI Test Delivers Rapid Breast Cancer Recurrence Predictions - New AI Test Delivers Rapid Breast Cancer Recurrence Predictions Thu, 09 Jul 2026 13:53:45 +0100